Effect of Pioglitazone on Left Ventricular Diastolic Function in Type 2 Diabetes Mellitus
Status:
Withdrawn
Trial end date:
2008-06-01
Target enrollment:
Participant gender:
Summary
This study is being done to determine if pioglitazone (Actos) is helpful to patients with
type 2 diabetes and could possibly prevent harmful consequences of cardiovascular disease in
diabetic patients.